Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Implementing Shared Decision Making in Hemophilia Patient CareRelease Date:Quality Improvement Rare Disease USA Improving the Vaccination Environment to Prevent Respiratory Infectious Diseases in Older Adults and High-Risk IndividualsRelease Date:Quality Improvement Vaccines Japan Improving Shared Decision Making in Hemophilia: Visiting Professorship Program - 2026, Semester 2Release Date:Partner: Hemostasis & Thrombosis Research Society (HTRS)Education Rare Disease USA Development of Healthcare Professionals with Advanced Expertise in Preventive Strategies in Pediatric Infectious DiseasesRelease Date:Education Vaccines Japan Current and Emerging Therapies: The future of Recurrent or Metastatic (r/m) Cervical CancerRelease Date:Education Oncology USA The Role of RSV in Functional Decline and Healthcare Dependency in Hospitalized AdultsRelease Date:Research Vaccines Italy Improving the Quality and Standardization of Pneumococcal Diagnostic Pathways in Pediatric and Adult PopulationsRelease Date:Research Vaccines Italy Interventional Research Studies of Brentuximab Vedotin-Based Novel Combinations in AITL and PTCL-NOSRelease Date:Research Oncology USA Optimizing Early Biomarker Testing to Guide Clinical Decision-Making in Colorectal Cancer Across Latin AmericaRelease Date:Education Oncology Argentina, Brazil, Chile, Colombia, Mexico, Peru Optimizing Maternal RSV Immunization Delivery: A Systems-Based QI Initiative to Improve Uptake, Equity, and Newborn OutcomesRelease Date:Quality Improvement Vaccines USA Evolving Treatment Options in First-Line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC)Education Oncology All Implementing Germline and Somatic Testing for Precision Medicine in Community-Based Prostate Cancer Care: Visiting ProfessorshipEducation Oncology USA Improving Venous Thromboembolism (VTE) Diagnosis and Treatment with Primary Care Settings- A Quality Improvement ProjectRelease Date:Partner: American Academy of Family PhysiciansQuality Improvement Internal Medicine USA Title Grant Type Focus Area Country Application Due Date Relapsed/Refractory Multiple Myeloma (United States and Western Europe, Japan, Singapore, Canada and Brazil)Release Date:Education Oncology All Aplastic Anemia - Patient Education and Support (Europe)Release Date:Education Internal Medicine All Review and analysis of retrospective, local source, serotype distribution for invasive pneumococcal diseaseRelease Date:Research Vaccines Algeria, Bahrain, Egypt, Iraq, Jordan, Kuwait, Lebanon, Libyan Arab Jamahiriya, Morocco, Oman, Qatar, Saudi Arabia, Tunisia, United Arab Emirates Enhance Clinical Research Capacity and Capability in ChinaRelease Date:Education Support for the Professions China Optimizing Telemedicine/Telehealth for the Rheumatology CommunityRelease Date:Education Inflammation & Immunology USA Quality of Care Initiative to Improve the Treatment of Locally Advanced or Metastatic (Stage IV) Bladder Cancer PatientsRelease Date:Partner: National Comprehensive Cancer Network, EMD SeronoQuality Improvement Oncology USA Multidisciplinary Gene Therapy Education - Recombinant Adeno-Associated Virus (rAAV)Release Date:Education Rare Disease All Quality Improvement Grants to Support the Delivery of Gene Therapies to Patients with Rare Disease by a Multidisciplinary TeamRelease Date:Quality Improvement Rare Disease All Improving NOAC adherence and persistence, initiatives for pharmacistsRelease Date:Quality Improvement Internal Medicine Israel Review and Analysis of Retrospective, Local Source, Serotype Distribution for Invasive Pneumococcal Disease in Latin AmericaRelease Date:Research Vaccines All Invasive Fungal Infections Research in ChinaRelease Date:Research Inflammation & Immunology China Addressing Knowledge Gaps in Inflammatory Bowel Disease (IBD) CareRelease Date:Education Inflammation & Immunology USA Treatment Optimization in ALK-positive Metastatic Non-Small Cell Lung CancerRelease Date:Education Oncology Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Iceland, Italy, Netherlands, Norway, Portugal, Spain, Swaziland, Sweden, USA, United Kingdom Immunotherapy in High-risk Non-Muscle Invasive Bladder CancerRelease Date:Education Oncology USA Advances in Migraine TreatmentRelease Date:Education Internal Medicine All 2022/2023 Global Obesity ASPIRERelease Date:Research Internal Medicine All Evolving Concepts in Biosimilar Optimization in Inflammatory DiseasesRelease Date:Education Inflammation & Immunology USA Underlying medical conditions and other risk factors, higher risk of severe COVID-19 (European)Release Date:Education Hospital All Building Capacity to Address Health Disparities in the US through AMS Telehealth and Tele-mentoringRelease Date:Quality Improvement Hospital USA 2022/2023 Global NASH ASPIRERelease Date:Research Internal Medicine All 2023 Growth Hormone ResearchRelease Date:Research Rare Disease All Antimicrobial Resistance Testing and Stewardship to Improve Hospitalized Patients’ Health OutcomesRelease Date:Quality Improvement Hospital All Medication Error Reduction Strategies in the Hospital SettingRelease Date:Education Hospital USA 2022/2023 Global Cachexia ASPIRERelease Date:Research Internal Medicine All Knowledge Gaps in the Clinical and Epidemiological Characteristics of RSVRelease Date:Education Vaccines USA Rapid Education on COVID-19 Outpatient TreatmentRelease Date:Education Hospital USA Real World Evidence for CDK 4/6 inhibitors in Shared Clinical Decision MakingRelease Date:Education Oncology USA PARP-inhibitor Combination Treatments in Prostate CancerRelease Date:Education Oncology USA 2022/2023 Global COVID-19 ASPIRERelease Date:Research Hospital All Engaging the Patient Community in Research and Publications (USA, Canada, Europe)Education Hospital All Providing Appropriate Medical Care for IBD PatientsRelease Date:Partner: Japanese Society for Inflammatory Bowel DiseaseQuality Improvement Inflammation & Immunology Japan Optimizing Canadian Telehealth Use for Women’s HealthRelease Date:Quality Improvement Internal Medicine Canada Gene Therapy Site-Preparedness Competitive Grant ProgramRelease Date:Partner: International Pharmaceutical Federation (FIP)Quality Improvement Rare Disease All Call for Independent Quality Improvement Grant Applications Oncology – Prostate CancerQuality Improvement Oncology USA Global Hemophilia Grant - Equity in Therapeutic Patient EducationRelease Date:Review Process: Expert Review PanelEducation Rare Disease All Gene and Gene-modified Cell Therapies Medical EducationRelease Date:Partner: American Society of Gene + Cell TherapyEducation Rare Disease All Cardiac Transthyretin Amyloid (ATTR) FellowshipRelease Date:Partner: International Society of AmyloidosisFellowship Rare Disease All Clinical Diagnosis and Management of EndometriosisEducation Internal Medicine USA Management of Uterine FibroidsEducation Internal Medicine USA Rapid Education on Drug-Drug Interactions in COVID-19 Outpatient TreatmentRelease Date:Education Hospital USA 2023 Global Migraine ASPIRERelease Date:Research Internal Medicine All Promoting Pain Treatment in Musculoskeletal PainRelease Date:Education Internal Medicine Japan Improve the Treatment Environment for Cancer Pain PatientsRelease Date:Education Internal Medicine Japan LMIC Pharmacovigilance EducationRelease Date:Education Patient Safety Kenya, Lesotho, Swaziland Knowledge Gaps in Managing Obesity and COVID-19Release Date:Education Hospital USA Immunotherapy in Urothelial Carcinoma (USA, Europe, Asia, Latin America, Canada, and Global)Release Date:Partner: Merck KGaA, Darmstadt, Germany, EMD SeronoEducation Oncology All Promoting timely diagnosis of ATTR-CM in China Competitive Grant Program - internal Pfizer review processRelease Date:Quality Improvement Rare Disease China Quality Improvement Initiatives to Address Healthcare Barriers for Cardiac AmyloidosisRelease Date:Partner: National Medical AssociationQuality Improvement Rare Disease USA